Insider filing · CSTL
Kristen M Oelschlager
Chief Operating Officer
profile →
Castle Biosciences, Inc.
CSTL · Healthcare · 53 filings in 24 months
ticker →
Kristen M Oelschlager sold $838K of Castle Biosciences (CSTL)
Executed Aug 24, disclosed Aug 26, 2 days later.
Value, as filed
$838K
24,602 sh across 3 lots
Executed
Aug 24
the trade date, as filed
Disclosed
Aug 26
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KOKristen M Oelschlager (Chief Operating Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Castle Biosciences, Inc. (CSTL). The largest single filing was $838K of CSTL (24,602 sh across 3 lots, as filed), executed Aug 24.
The name
CSTLHealthcare · Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers,…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Kristen M Oelschlager in CSTL
CSTLSALE
Castle Biosciences, Inc.
$135K4,486 sh × $30.00
Exec Aug 3
Filed Aug 5 · 4:18 PM ET CSTLSALE Castle Biosciences, Inc. $200K
8,186 sh × $24.40
Exec Jul 1
Filed Jul 6 · 4:24 PM ET CSTLSALE Castle Biosciences, Inc. $178K
8,587 sh × $20.71
Exec Jun 16
Filed Jun 18 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $585K
14,888 sh × $39.31
Exec Dec 17 2025
Filed Dec 19 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $665K
18,932 sh × $35.10
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $317K
12,678 sh × $25.04
Exec Oct 31 2025
Filed Nov 4 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $391K
18,007 sh × $21.69
Exec Aug 27 2025
Filed Nov 4 2025 · 5:30 PM ET † CSTLSALE Castle Biosciences, Inc. $391K
18,007 sh × $21.69
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET